DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DMA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
MAY 3, 1985 
The Recombinant DNA Advisory Committee (RAC) was convened for its thirty-second 
meeting at 9:00 a.m. on May 3, 1985, in Building 31, Conference Room 6, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20205. 
Mr. Robert Mitchell (Chair), Attorney at Law in California, presided. In 
accordance with Public Law 92-463, the meeting was open bo the public. The 
following were present for all or part of the meeting: 
Committee members: 
Roys ton Clowes 
Mitchell Cchen 
L. Albert Daloz 
Bernard Davis 
David Friedman 
Susan Gottesman 
Irving Johnson 
Wolfgang Jcklik 
Arthur Lardy 
David Martin 
Mark Mills 
Robert Mitchell 
Thomas Pircne 
David Pramer 
Fred Rapp 
Mark Saginor 
A committee roster is attached (Attachment I). 
Ad hoc consultant: 
Frances Sharpies 
Anne Vidaver 
LeRoy Walters 
Pieter Wensink 
Anne Witherby 
William J. Gartland, Jr. 
(Executive Secretary) 
Gerard McGarrity, Institute for Medical Research 
Non-voting members : 
William Beisel, Department of Defense 
George Du da , Department of Energy 
John R. Fcwle, Environmental Protection Agency 
Philip D. Harriman, National Science Foundation 
Morris A. Levin, Environmental Protection Agency 
Henry I. Miller, Food and Drug Administration 
Edwin Shykird, Department of Commerce 
Sue A. Tolin, Department of Agriculture 
William J. Walsh, Department of State 
1 The RAC is advisory to the NIH, and its recommendations should not be considered 
as final or accepted. The Office of Recombinant DNA Activities should be 
coasulted for NIH policy on specific issues. 
[ 122 ] 
